RNA-seq Pipeline

RNA-seq Pipeline processes RNA sequencing (RNA-seq) data from next-generation sequencing to align reads, generate signal tracks, and quantify genes and isoforms to support clinical genetic diagnosis and detection of splicing-related regulatory events.


Key Features:

  • Alignment of Reads: Aligns RNA-seq reads to reference genomes to provide accurate mapping for downstream analyses.
  • Signal Track Generation: Generates signal tracks representing expression levels across genomic regions for quantitative and visual interpretation.
  • Quantification of Genes and Isoforms: Quantifies gene expression and transcript isoforms to capture differential splicing and variant expression.
  • Variant Identification and Annotation: Identifies, annotates, and classifies sequence variants from RNA-seq data.
  • Next-generation Sequencing Support: Processes RNA-seq datasets produced by next-generation sequencing technologies.
  • Provenance: Implementation originates from the ENCODE-DCC RNA-sequencing pipeline.

Scientific Applications:

  • Clinical Genetic Diagnosis: Aids identification, annotation, and classification of sequence variants in clinical genetic diagnosis and enhances detection of splicing events and variants, potentially increasing diagnostic rates by 10–35%.
  • Splicing and Regulatory Event Analysis: Links differential splicing and other regulatory events to disease phenotypes.
  • Transcriptome Profiling: Profiles transcriptome variation across tissue types, cellular conditions, and environmental factors.

Methodology:

The pipeline employs advanced bioinformatics processing algorithms and computational and statistical tools, may require customization for specific diseases, and emphasizes best practices in RNA-seq analysis.

Topics

Details

License:
MIT
Tool Type:
workflow
Programming Languages:
Shell, Python
Added:
1/14/2020
Last Updated:
1/14/2021

Operations

Publications

Marco-Puche G, Lois S, Benítez J, Trivino JC. RNA-Seq Perspectives to Improve Clinical Diagnosis. Frontiers in Genetics. 2019;10. doi:10.3389/fgene.2019.01152. PMID:31781178. PMCID:PMC6861419.

PMID: 31781178
PMCID: PMC6861419
Funding: - Federación Española de Enfermedades Raras: PI16/00440